DRR:ASXDeterra Royalties Ltd Analysis
Data as of 2026-06-21 - not real-time
A$4.43
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Deterra Royalties is trading below its recent moving averages, with price comfortably above the 200‑day trend line, indicating a generally bullish backdrop. The stock benefits from a strong dividend yield and a payout ratio that suggests current earnings can comfortably fund the distribution, while free cash flow remains robust despite a high debt load. Technical signals are mixed: the MACD histogram is marginally negative and the RSI hovers near neutral, but the overall trend remains bullish and volume is stable. Valuation models point to a modest upside relative to the current price, and analyst consensus leans toward a buy recommendation, reinforcing the case for investors seeking income and exposure to a diversified royalty portfolio.
The primary risks stem from the company's elevated leverage and the cyclical nature of the basic materials sector, which could pressure earnings if commodity prices soften. However, the low beta indicates limited price volatility relative to the market, and the extensive geographic footprint spreads country‑specific regulatory and currency exposures. In summary, the stock offers a balanced mix of income, modest capital appreciation potential, and diversified royalty assets, making it attractive for investors with a medium‑to‑long‑term horizon.
The primary risks stem from the company's elevated leverage and the cyclical nature of the basic materials sector, which could pressure earnings if commodity prices soften. However, the low beta indicates limited price volatility relative to the market, and the extensive geographic footprint spreads country‑specific regulatory and currency exposures. In summary, the stock offers a balanced mix of income, modest capital appreciation potential, and diversified royalty assets, making it attractive for investors with a medium‑to‑long‑term horizon.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price near identified support level
- mixed MACD signal with slight bearish tilt
- high dividend yield providing downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- modest upside to fair‑value estimate
- analyst consensus of buy and target price above current level
- sustainable dividend supporting total return
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- diversified royalty portfolio across multiple commodities and jurisdictions
- strong free cash flow generation to service debt and fund dividends
- low beta indicating limited market volatility over extended horizons
Key Metrics & Analysis
Financial Health
Revenue Growth8.10%
Profit Margin65.67%
P/E Ratio13.0
ROE149.19%
ROA36.60%
Debt/Equity112.65
P/B Ratio16.9
Op. Cash FlowA$172.6M
Free Cash FlowA$151.6M
Technical Analysis
TrendBullish
RSI48.3
SupportA$4.26
ResistanceA$4.74
MA 20A$4.50
MA 50A$4.36
MA 200A$4.19
MACDBearish
VolumeStable
Fear & Greed Index91.46
Valuation
Fair ValueA$5.03
Target PriceA$4.65
Upside/Downside4.87%
GradeUndervalued
TypeBlend
Dividend Yield5.60%
Risk Assessment
Beta0.54
Volatility22.16%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.